Menu
GeneBe

12-121001112-G-A

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_000545.8(HNF1A):c.1816G>A(p.Gly606Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000287 in 1,461,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000029 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

HNF1A
NM_000545.8 missense

Scores

3
14

Clinical Significance

Benign reviewed by expert panel U:1B:1

Conservation

PhyloP100: 2.55
Variant links:
Genes affected
HNF1A (HGNC:11621): (HNF1 homeobox A) The protein encoded by this gene is a transcription factor required for the expression of several liver-specific genes. The encoded protein functions as a homodimer and binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Defects in this gene are a cause of maturity onset diabetes of the young type 3 (MODY3) and also can result in the appearance of hepatic adenomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]
C12orf43 (HGNC:25719): (chromosome 12 open reading frame 43) Predicted to be involved in Spemann organizer formation and negative regulation of Wnt signaling pathway. Predicted to be located in nuclear envelope. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07462931).
BP6
Variant 12-121001112-G-A is Benign according to our data. Variant chr12-121001112-G-A is described in ClinVar as [Benign]. Clinvar id is 1687069.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr12-121001112-G-A is described in Lovd as [Likely_pathogenic].
BS2
High AC in GnomAdExome at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HNF1ANM_000545.8 linkuse as main transcriptc.1816G>A p.Gly606Ser missense_variant 10/10 ENST00000257555.11
C12orf43NM_022895.3 linkuse as main transcriptc.*3041C>T 3_prime_UTR_variant 6/6 ENST00000288757.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HNF1AENST00000257555.11 linkuse as main transcriptc.1816G>A p.Gly606Ser missense_variant 10/101 NM_000545.8 P4
C12orf43ENST00000288757.7 linkuse as main transcriptc.*3041C>T 3_prime_UTR_variant 6/61 NM_022895.3 P2

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
1
AN:
152216
Hom.:
0
Cov.:
33
FAILED QC
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000479
AC:
12
AN:
250720
Hom.:
0
AF XY:
0.0000664
AC XY:
9
AN XY:
135604
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000883
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000287
AC:
42
AN:
1461688
Hom.:
0
Cov.:
33
AF XY:
0.0000385
AC XY:
28
AN XY:
727132
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000429
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.0000662
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000657
AC:
1
AN:
152216
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74352
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000496
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000494
AC:
6

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Maturity-onset diabetes of the young type 3 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingDepartment Of Endocrinology, Sanjay Gandhi Postgraduate Institute Of Medical SciencesAug 15, 2023Heterozygous missense variation in exon 9 of the HNF1A gene (chr12:g.121001112G>A) that results in the amino acid substitution of Serine for Glycine at codon 637. The variant has not been reported in the 1000 genomes database and has a frequency of 0.000007 in the gnomAD genomes database. The in silico prediction of the variant is damaging by MutationTaster2, and benign by PolyPhen2 and SIFT. The variant has previously been described in a patient with suspected MODY (PMID: 22432108). However, a later publication examining the functional significance of the variant found that it was of uncertain significance/likely benign (PMID: 32910913). PP2, BP6 -
Monogenic diabetes Benign:1
Benign, reviewed by expert panelcurationClinGen Monogenic Diabetes Variant Curation Expert PanelApr 17, 2022The c.1816G>A variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of glycine to serine at codon 606 (p.(Gly606Ser)) of NM_000545.8. This variant has a Popmax Filtering allele frequency in gnomAD 2.1.1 of 0.0001763, which is greater than or equal to the MDEP threshold for BA1 (greater than or equal to 0.0001) (BA1). Functional studies demonstrated the p.Gly606Ser protein has DNA binding above 75% of wild type and abnormal nuclear localization/transactivation above 75% of wildtype, indicating that this variant does not impact protein function (PMID: 32910913) (BS3_Supporting). This variant was identified in an individual with diabetes; however, the MODY probability is unable to be calculated due to insufficient clinical information, and PP4 cannot be applied (PMID: 22432108). In summary, c.1816G>A meets the criteria to be classified as benign for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved 9/30/21): BA1, BS3_Supporting. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.069
T
BayesDel_noAF
Uncertain
-0.030
Cadd
Benign
11
Dann
Benign
0.63
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.25
FATHMM_MKL
Benign
0.70
D
LIST_S2
Benign
0.78
T;T;T;T;T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.075
T;T;T;T;T
MetaSVM
Benign
-0.70
T
MutationTaster
Benign
0.64
N;N;N;N
PrimateAI
Benign
0.38
T
PROVEAN
Benign
0.20
N;.;.;N;N
REVEL
Uncertain
0.48
Sift
Benign
0.88
T;.;.;T;T
Sift4G
Benign
1.0
T;T;T;T;T
Polyphen
0.0030
.;.;.;.;B
Vest4
0.20
MutPred
0.36
.;.;.;.;Gain of phosphorylation at G613 (P = 0.0248);
MVP
0.98
MPC
0.12
ClinPred
0.017
T
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs753972576; hg19: chr12-121438915; API